Despite the profound impact of coronary artery disease on human health, the origins of the coronary blood vessels are poorly understood. Wu et al. use imaging and genetic techniques to show that the endocardium contributes to the coronary vessels and that the coronary arteries and veins have multilineage origins.
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Although millions of people each year die from an epidemic of heart failure secondary to coronary artery disease, little is known about the origins of the coronary circulation and the molecular pathways that underpin its development. Coronary arteries and veins have long been thought to have distinct developmental origins (Lewis, 1904; Poelmann et al., 1993; Lavine et al., 2008) , with the veins sprouting from the endothelium of the main inflow vessel of the heart, the sinus venosus, and the arteries arising from within the myocardium. However, further progress has been hampered by controversy, species differences, and the inherent limitations of lineage tracing techniques. In this issue, Zhou and colleagues provide evidence that the endocardium-the endothelial lining of the developing heart-is a major source of coronary artery endothelial cells (Wu et al., 2012) (Figure 1D ).
From prior work, it is known that endocardial cells of the developing heart are highly plastic and undergo a regional epithelial-to-mesenchymal transition (EMT) and enter matrix-rich swellings called endocardial cushions, which are then remodeled into cardiac valves. Physical and clonal connections between the endocardium and coronary vessels have also been discovered (Lewis, 1904; Poelmann et al., 1993; Virá gh and Challice, 1981; Red-Horse et al., 2010) , but the notion of a major contribution of endocardium to the coronary arteries has never taken hold.
Instead, center stage has been held by a diminutive villous epithelium, termed the proepicardium (PE), which early fate mapping studies fingered as the likely source of coronary vessels. The PE derives from the early heart progenitor fields and comes to sit on top of the forming liver and next to the sinus venosus, potentially as a multipotent progenitor population. The PE gives rise to the epicardium, which undergoes EMT to generate epicardial-derived cells (EPDCs) that contribute to the coronary vessels ( Figure 1B) .
A variety of lineage tracing approaches have shown compellingly that the EPDCs contribute smooth muscle cells to the coronary vessels and both adventitial and interstitial fibroblasts. Our recent data suggest that multipotent mesenchymal stem cell-like colony-forming cells that persist into adulthood might also be derived from the PE (Chong et al., 2011) . The striking suggestion from Cre-lineage tracing of the PE and epicardium that substantial swathes of myocardium also have their origins in the PE now seems unlikely, or the extent is much more modest than initially suggested, because of the limitations of Cre-recombinase reagents (Rudat and Kispert, 2012) .
Whether endothelial cells are also contributed to the coronary vessels via the epicardial route has been contentious and, though the PE may indeed have some potency toward endothelial cell fate, it now seems likely that some of the early lineage tracking methods used to trace epicardial fate also mark endothelial cells or angioblasts in the core of the PE that are in continuity with the liver sinuses or sinus venosus. Consistent with the variable results from these early lineage studies, initial lineage tracing of epicardial fate using Cre-recombinase methods also showed either no contribution to coronary endothelial cells or a minor one, depending on the Cre driver strain used. Indeed, a recent study claiming to have resolved the longstanding controversy by pointing out molecular heterogeneity within the PE did not specifically address the possibility that the new Cre reagents used capture some existing endothelial cells (Katz et al., 2012) .
So just how might endothelial cells within or around the PE find their way into the myocardial wall to form the coronaries? As noted, it remains possible that some PE cells carry endothelial potency, although it is also possible that local epithelial cells or angioblasts are swept along with the epicardium, perhaps at the core of vesicles that bud off from proepicardial villi. Recently, Red-Horse et al. (2010) revisited with contemporary tools what has been known for over a century-that the endothelium of the sinus venosus undergoes angiogenic sprouting into the subepicardial matrix and then across the whole heart to give rise to the venous circulation ( Figure 1C ). The subepicardial route is distinct from the superficial trajectory of the epicardium. Clonal analysis suggested that the sinus venosus also seeds part of the arterial plexus, and, of note, some clones were found to contain both coronary endothelium and endocardium, but not sinus venosus, highlighting the possibility that endocardial cells contribute to some vessels.
The study from Zhou and colleagues reported in this issue (Wu et al., 2012) suggests a much more significant contribution to the coronary arteries from the endocardium than previously suggested ( Figure 1D) . The study uses a knockin of Cre recombinase into the nuclear factor of activated T cells 1c (NFAT1c) locus, as well as a conditional NFAT1c-Cre transgenic/knockin configuration, to trace the fate of endocardium. NFAT1c is expressed predominantly in the endocardium, but not coronary vessels or PE, although a partial overlap of expression and lineage relationship with the sinus venosus is noted. Nevertheless, the major outcome of lineage tracing with NFAT1c-Cre is compelling labeling of the endothelium of coronary arteries with a more modest contribution to veins. Venous and arterial endothelial identity is discerned in this study using specific markers and the predominantly deep position of the arterial plexus and subepicardial position of the venous plexus, as seen previously (Lavine et al., 2008) . The labeling pattern contrasts that of lineage tracing using a Tie2-Cre strain, which more robustly marks the subepicardial venous plexus. In the Zhou study, no contribution is seen to smooth muscle, excluding involvement of the PE.
The extensive clonal lineage tracing performed is a particularly important part of this study, with the size of clonal contribution to the endocardium correlating with that found in the arterial plexus, although not with that in the venous plexus. Whether clones extend into the sinus venosus is not specifically scored in this study; however, differing from the Red-Horse study (Red-Horse et al., 2010) , which focused on the sinus venosus origin of the venous plexus, Wu et al. stress the strong clonal relationship between endocardium and the coronary arterial plexus. The angiogenic nature of ventricular endocardium is further demonstrated in explant culture by the fact that endocardium is shown to migrate through the entire myocardial wall and form a vascular plexus on underlying Matrigel when stimulated with vascular endothelial growth factor 120. Likewise, in quail/chick embryo chimera experiments, quail endocardial cells are seen to traverse the chick myocardial wall when transplanted against its outer (B) Epicardial origin. At E9.5, the proepicardium releases cell clusters or vesicles to the pericardial cavity that attach to the myocardial wall and spread to give rise at E11.5 to the epicardium and epicardial-derived cells (arrows, route 1), which differentiate predominantly into smooth muscle cells of the coronary plexus and cardiac fibroblasts (right). Some existing endothelial cells or angioblasts derived from the liver sinusoids may be swept along with or encapsulated by proepicardial clusters (white arrows and route 2). Some PE cells may be multipotent for endothelial cells, perivascular cells, and fibroblasts (asterisk, route 3). (C) Sinus venosus origin. At E10.5, the sinus venosus endothelium sprouts into and around the subepicardial space of the atrium (arrows) and ventricles (arrowhead) and by E12.5 (box, right) has formed the venous and possibly parts of the arterial coronary endothelial plexus (Red-Horse et al., 2010) . (D) Endocardial origin. At E10.5, endocardial cells of the ventricles undergo budding, sprouting, or EMT directly to form at E11.5 (box, right) endothelial cells of the coronary arteries and possibly of some of the veins (Wu et al., 2012) . Abbreviations: a, atrium; avc, atrioventricular canal; ca, coronary arteries; cv, coronary veins; EPDCs, epicardial-derived cells; epi, epicardium; f, fibroblasts; lp, liver primordium; lv, left ventricle; oft, outflow tract; pe, proepicardium; rv, right ventricle; SMCs, smooth muscle cells; subepi, subepicardium; sv, sinus venosus; v, ventricle.
surface and then contribute extensively to the arterial plexus. PE cells could only contribute to subepicardial vessels.
Finally, mouse fetuses conditionally deleted for Vegf-a in myocardium or for the Vegf receptor-2 (Vegfr2) gene in endocardium show coronary hemorrhage and a substantial reduction of the arterial endothelial plexus, with the subepicardial venous plexus more modestly affected, reinforcing the notion of distinct molecular pathways guiding the different contributors to the coronary circulation.
The Wu et al. study makes a valuable contribution to the ongoing debate on the origins and mechanism of formation of the coronary vascular tree. Indeed, it seems possible that the coronaries have a multilineage origin (Figure 1) , although dissecting the precise contributions from the endocardium and sinus venosus (and PE) will require further work. High-resolution and real-time imaging to detect sprouting, budding, or EMT of endocardium will surely follow this study.
Contrasting suggestions that a cardiac hemogenic endothelium arises within the coronary arterial plexus (Red-Horse et al., 2010) and that the venous plexus has a hemopoietic origin and harbors hemoangioblastic cells (Lavine et al., 2008) require further study to fit into the current framework.
The results reflect the plasticity of the early endocardium and sinus venosus, and they may have implications for how we think about and study vascular plasticity in pathologies such as cancer and during revascularization and reparative therapies, including stem cell therapies, for the diseased heart.
The mammalian brain comprises a diverse variety of cell types. Fine characterization of specific subpopulations of neurons, however, has been a technical challenge. Here, Knight et al. describe an elegant technique for high throughput of molecular profiling of activated hypothalamic neurons.
Technological advancements provide platforms for landmark discoveries, thereby helping to solve age-old problems. The complexity of the central nervous system and the limited number of tools available to dissect intricate networks deep in the brain, such as the hypothalamus, have posed significant limitations in the field of energy metabolism regulation. In this issue of Cell, Knight et al. (2012) develop a method to selectively characterize the transcriptome of neurons in response to stimuli within the hypothalamus.
Several techniques have been developed to unravel intricate brain circuits. Some of these approaches involve identification of target neuronal populations based on the specific or quasispecific genetic profile of these cells. Utilizing specific promoter-induced transcription of ectopic proteins (e.g., cre recombinase, green fluorescent protein [GFP] , and ChR2), it is possible to selectively target neuronal populations and allow testing of their function in the circuitry. To date, however, transcriptional markers
